Binimetinib, MEK1/2 inhibitor (TBI4789)

Description

Product Details

Formal Name: 6-(4-Bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide

Alternate Names: ARRY-162; MEK162

Molecular Formula: C₁₇H₁₅BrF₂N₄O₃

Formula Weight: 441.23

CAS Number: 606143-89-9

Purity: >98%

Formulation: powder

Solubility: Soluble in DMSO (up to at least 25 mg/ml)

Storage: -20°C

Stability: ≥ 1 year.

 

Applications

MEK1/2 inhibitor

 

Functions

Binimetinib (606143-89-9) is a potent (IC50 = 12 nM) and selective allosteric inhibitor of MEK1/2. Recently approved by the FDA for treatment of melanoma in combination with Encorafenib. Binimetinib has had limited success as monotherapy but has shown promise in combination with other chemotherapeutic agents.

 

Application Procedures

First dissolved in DMSO (up to at least 25 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 3 months.

Additional information

SIZE (mg)	25 MG, 5 MG

Datasheet:

TBI4789_Binimetinib

MSDS:

TBI4789_Binimetinib_MSDS_2024